Log In
Print
BCIQ
Print
Print this Print this
 

EPIAO

  Manage Alerts
Collapse Summary General Information
Company 3SBio Inc.
DescriptionRecombinant human erythropoietin (EPO) injection
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsTreat anemia associated with chemotherapy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today